Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason N Berman

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Blood|July 28, 2021
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trialJohann Hitzler, Todd Alonzo, Robert Gerbing, et al.
Journal of Medical Genetics|September 6, 2015
Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN)Santhosh Dhanraj, Sethu Madhava Rao Gunja, Adam P Deveau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing SarcomaSarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Blood Advances|October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual DiseaseJason N Berman, Anupam Verma, Shelton A Viola, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Cancer Cell|May 13, 2015
Translational Activation of HIF1α by YB-1 Promotes Sarcoma MetastasisAmal M El-Naggar, Chansey J Veinotte, Hongwei Cheng, et al.
EMBO Molecular Medicine|April 9, 2025
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframeGeorgina D Barnabas, Tariq A Bhat, Verena Goebeler, et al.
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
JCI Insight|December 22, 2022
Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammationCatherine M Biggs, Anna Cordeiro-Santanach, Sergey V Prykhozhij, et al.
American Journal of Human Genetics|February 8, 2020
The Canadian Rare Diseases Models and Mechanisms (RDMM) Network: Connecting Understudied Genes to Model OrganismsKym M Boycott, Philippe M Campeau, Heather E Howley, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Blood|July 28, 2021
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trialJohann Hitzler, Todd Alonzo, Robert Gerbing, et al.
Journal of Medical Genetics|September 6, 2015
Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN)Santhosh Dhanraj, Sethu Madhava Rao Gunja, Adam P Deveau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing SarcomaSarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.
Blood Advances|October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual DiseaseJason N Berman, Anupam Verma, Shelton A Viola, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Cancer Cell|May 13, 2015
Translational Activation of HIF1α by YB-1 Promotes Sarcoma MetastasisAmal M El-Naggar, Chansey J Veinotte, Hongwei Cheng, et al.
EMBO Molecular Medicine|April 9, 2025
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframeGeorgina D Barnabas, Tariq A Bhat, Verena Goebeler, et al.
Cancer Cell|June 15, 2021
STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaBiniam Adane, Gabriela Alexe, Bo Kyung A Seong, et al.
JCI Insight|December 22, 2022
Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammationCatherine M Biggs, Anna Cordeiro-Santanach, Sergey V Prykhozhij, et al.
American Journal of Human Genetics|February 8, 2020
The Canadian Rare Diseases Models and Mechanisms (RDMM) Network: Connecting Understudied Genes to Model OrganismsKym M Boycott, Philippe M Campeau, Heather E Howley, et al.
Pageof 11